Literature DB >> 9220406

Decreasing choline signal--a marker of phenylketonuria?

M Dezortová1, L Hejcmanová, M Hájek.   

Abstract

We found a statistically significant increase in the N-acetylaspartate/choline-containing compounds (NAA/Cho) ratio in a group of 69 phenylketonuria (PKU) patients with a rise in echo time (TE) compared with a group of 35 age-matched controls. The absolute concentration of creatine did not differ significantly between patients and controls, but a significant difference was found for choline-containing compounds (1.33 mM in patients vs. 1.53 mM in controls, p < 0.0209). The change in NAA/Cho (for TE = 270 ms: 2.52 in patients vs. 1.96 in controls, p270 < 0.0001) can be explained by a significant difference in T2 values of choline compounds between patients and controls. This result shows that the difference in the ratios of signal intensities often used for the description of different pathologies can be explained not only by changes in the absolute metabolite concentration but also by changes in the mobility reflected by relaxation times.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9220406     DOI: 10.1007/bf01772005

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  27 in total

1.  Neurological deterioration in adult phenylketonuria.

Authors:  D Villasana; I J Butler; J C Williams; S M Roongta
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Proton NMR spectroscopy of Canavan's disease.

Authors:  P B Barker; R N Bryan; A J Kumar; S Naidu
Journal:  Neuropediatrics       Date:  1992-10       Impact factor: 1.947

3.  Localized brain proton NMR spectroscopy in young adult phenylketonuria patients.

Authors:  K Johannik; P Van Hecke; B François; G Marchal; M H Smet; J Jaeken; L Breysem; G Wilms; A L Baert
Journal:  Magn Reson Med       Date:  1994-01       Impact factor: 4.668

4.  In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment.

Authors:  H E Möller; P Vermathen; K Ullrich; J Weglage; H G Koch; P E Peters
Journal:  Neuropediatrics       Date:  1995-08       Impact factor: 1.947

5.  In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy.

Authors:  E J Novotny; M J Avison; N Herschkowitz; O A Petroff; J W Prichard; M R Seashore; D L Rothman
Journal:  Pediatr Res       Date:  1995-02       Impact factor: 3.756

6.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites.

Authors:  J Frahm; H Bruhn; M L Gyngell; K D Merboldt; W Hänicke; R Sauter
Journal:  Magn Reson Med       Date:  1989-07       Impact factor: 4.668

7.  Cranial CT and MRI in malignant phenylketonuria.

Authors:  F Gudinchet; P Maeder; R A Meuli; T Deonna; J M Mathieu
Journal:  Pediatr Radiol       Date:  1992

8.  In vivo 1H MRS choline: correlation with in vitro chemistry/histology.

Authors:  B L Miller; L Chang; R Booth; T Ernst; M Cornford; D Nikas; D McBride; D J Jenden
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

9.  Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study.

Authors:  B M Cohen; P F Renshaw; A L Stoll; R J Wurtman; D Yurgelun-Todd; S M Babb
Journal:  JAMA       Date:  1995-09-20       Impact factor: 56.272

10.  Biochemical control, genetic analysis and magnetic resonance imaging in patients with phenylketonuria.

Authors:  J H Walter; L A Tyfield; J B Holton; C Johnson
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

View more
  3 in total

Review 1.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

2.  Application of LCModel for quality control and quantitative in vivo 1H MR spectroscopy by short echo time STEAM sequence.

Authors:  M Hájek; M Burian; M Dezortová
Journal:  MAGMA       Date:  2000-02       Impact factor: 2.310

3.  Cranial MR spectroscopy of tetrahydrobiopterin deficiency.

Authors:  Yin-Hsiu Chien; Shiin-Feng Peng; Tso-Ren Wang; Wuh-Liang Hwu
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.